# BriaCell Therapeutics Corp.: Form 8-K, filed Oct 2, 2024

- Company: [BriaCell Therapeutics Corp.](/companies/bctx.md) (CIK 1610820)
- Form: 8-K
- Filed: 2024-10-02
- Accepted by EDGAR: Oct 2, 2024, 16:30 ET
- Period: 2024-10-01
- Accession: 0001493152-24-039218
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1610820/000149315224039218/form8-k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1610820/000149315224039218/

## Items reported

- Item 1.01: Entry into a material agreement
- Item 8.01: Other events
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1610820/000149315224039218/form8-k.htm

Filed Oct 2, 2024.
Source: SEC EDGAR, the filing index for accession 0001493152-24-039218. Last ingested by Listed: Oct 24, 2026, 15:07 ET. No prices; not investment advice.